Dongsung Chemical Co., Ltd.

KRX:102260.KS

4345 (KRW) • At close September 6, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2023202220212020201920182017201620152014201320122011201020092008
Revenue 1,117,998.8541,140,123.62925,978.52882,050.841849,786.144813,073.125827,336.387852,912.858871,224.899905,441.155823,409.697654,021.296582,112.775505,111.439529,645.397288,366.171
Cost of Revenue 944,251.796994,564.1788,827.449718,908.053701,871.558718,053.309735,222.486697,126.952718,164.252772,929.478706,293.035546,835.126503,706.822433,499.398436,055.247254,711.395
Gross Profit 173,747.058145,559.52137,151.071163,142.788147,914.58695,019.81692,113.901155,785.906153,060.647132,511.677117,116.663107,186.1778,405.95371,612.04193,590.1533,654.776
Gross Profit Ratio 0.1550.1280.1480.1850.1740.1170.1110.1830.1760.1460.1420.1640.1350.1420.1770.117
Reseach & Development Expenses 3,529.8512,284.7491,793.2152,041.0572,564.8281,743.5251,452.5721,697.9971,242.781,216.166426.702517.381,578.956140.997439.608253.76
General & Administrative Expenses 8,780.1298,215.4557,817.4087,353.7578,450.7987,200.8046,975.7129,845.18810,580.558,298.5498,426.7467,507.4215,654.8047,095.2415,153.1894,432.305
Selling & Marketing Expenses 29,741.87432,702.4129,790.06625,502.49624,925.43122,990.23823,446.77526,547.65222,500.74526,284.44524,194.87417,574.43513,203.84411,767.63513,191.1148,119.681
SG&A 87,294.42840,917.86537,607.47432,856.25233,376.22930,191.04230,422.48736,392.8433,081.29434,582.99432,621.62125,081.85618,858.64918,862.87528,344.30312,551.986
Other Expenses -1,562.83246,895.18748,119.63267,071.83259,743.6111,314.9191,478.856509.6344,999.078-5,001.422928.7962,689.598-5,501.3733,189.3621,337.981250.773
Operating Expenses 92,387.11190,097.887,520.32101,969.14195,684.66787,042.18688,459.39190,746.38286,372.63682,481.89473,179.97263,062.09753,145.71846,873.09956,717.10727,906.413
Operating Income 81,359.94755,370.34345,320.05561,173.64751,825.7327,777.6293,654.5165,039.52466,688.01150,029.78343,936.69144,124.07324,634.03424,738.94336,873.0425,748.363
Operating Income Ratio 0.0730.0490.0490.0690.0610.010.0040.0760.0770.0550.0530.0670.0420.0490.070.02
Total Other Income Expenses Net -7,151.578402.3558,315.685-12,673.055-16,558.996-5,047.502-2,291.6035,410.787-9,397.566-18,655.609-15,254.014-6,451.628-15,988.345-6,985.343-49,066.703-1,581.573
Income Before Tax 74,208.36955,772.69853,635.7448,500.59235,266.7372,930.1271,362.90670,450.3157,290.44531,374.17328,682.67837,672.4459,271.8917,753.599-12,193.664,166.79
Income Before Tax Ratio 0.0660.0490.0580.0550.0420.0040.0020.0830.0660.0350.0350.0580.0160.035-0.0230.014
Income Tax Expense 9,770.6018,939.70412,195.9511,318.95410,246.2187,754.337,294.92617,471.02413,733.6492,268.83510,635.0737,464.5527,168.9478,452.1413,446.1072,826.771
Net Income 33,453.89946,832.99441,439.7937,181.63725,020.518-3,219.199,812.50837,468.98620,287.7547,282.277598.91814,824.065-1,778.2511,873.133902.619-8,515.858
Net Income Ratio 0.030.0410.0450.0420.029-0.0040.0120.0440.0230.0080.0010.023-0.0030.0040.002-0.03
EPS 687.49954.02858.8845.17568.74-73.1822384650820322554-75.1483.244.6-540.2
EPS Diluted 681.71945.62846.84839.39560.69-7322083049719918401-59.9183.244.6-540.2
EBITDA 107,795.26387,050.89885,576.15991,972.23881,087.05938,753.56626,768.86596,408.78697,373.53264,874.80460,023.15665,241.01439,388.85550,876.99222,784.74615,720.578
EBITDA Ratio 0.0960.0760.0920.1040.0950.0480.0320.1130.1120.0720.0730.10.0680.1010.0430.055